APOB and lung carcinoma: Although the exact pathways are not the same across different types of cancer, targeted therapies for lung cancer have been found to induce expression of cytosine deaminases like APOBECs (apolipoprotein B mRNA editing enzymes, catalytic polypeptide-like) [29,30].